CTLA4 and colonic neoplasm: In preclinical experiments on a murine colon cancer model (CT-26), a double blockade of CTLA-4 and PD-L1 enhanced tumor rejection and completely inhibited liver metastasis, while blocking CTLA-4 or PD-L1 alone caused a decrease in liver metastasis.